Investor Relations

Redpoint Bio is leveraging recent discoveries in the molecular biology of taste to discover and develop novel taste modulators for the food and beverage industries. Redpoint is focused on the development of healthier foods and beverages as well as new approaches to the treatment of diabetes and obesity.

Recent scientific research suggests that many of the same taste-signaling components found on the tongue are also expressed as part of a nutrient-sensing system located in the gastrointestinal tract. This could lead to potential opportunities for the discovery of novel diabetes or obesity therapeutics.

Stock Information

RPBC - (OTC: BB) 0.16 + 0.00 Nov 6, 2009 12:53 PM

Recent Releases

Sep 1, 2009
Redpoint Bio to Present at Rodman & Renshaw Annual Global Investment Conference

Aug 13, 2009
Redpoint Bio Reports Three Months and Six Months 2009 Results

Events

Nov 6, 2009
Investor Presentation

Sep 24, 2009
Presentation on RP44 by Dr. Ray Salemme, CEO